Skip to main content
Glama

clinicaltrials_study

Read-onlyIdempotent

Search ClinicalTrials.gov studies (free, no key). Returns NCT ids, brief titles, status and start date with study URLs. Use for registered clinical trial records.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
limitNoMax studies, default 10, max 100
queryYesSearch terms, e.g. melanoma immunotherapy

Output Schema

TableJSON Schema
NameRequiredDescriptionDefault
dataYesSource payload; fields vary per tool
sourceYesHuman-readable upstream source name
retrievedAtYesISO-8601 timestamp of retrieval

Schema Changelog

Changes observed during successful MCP inspections.

  1. Added

TDQS

A3.9/5.0
Behavior3/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, openWorldHint and destructiveHint=false, so the safety profile needs no restating. The description adds one genuinely useful behavioral fact beyond that — no API key required — but says nothing about rate limits, pagination across the 100-result cap, or result freshness.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Three short, front-loaded sentences with no filler; purpose leads and usage follows. The enumeration of return fields is somewhat redundant given an output schema exists, which keeps it just below a 5.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a two-parameter search tool with an output schema and full annotation coverage, the description supplies everything needed to invoke it correctly: source, auth requirement, and use case. Only explicit sibling routing and pagination/rate-limit notes are missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so both parameters (query, limit) are already documented with examples and a default/max. The description adds no additional syntax guidance, so the baseline 3 for schema-driven parameters is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb and resource ("Search ClinicalTrials.gov studies") and names the exact registry, which cleanly separates it from the many literature siblings such as pubmed_search, europepmc_search and semantic_scholar_works. The return contents (NCT ids, brief titles, status, start date, study URLs) further pin down what an agent gets back.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

"Use for registered clinical trial records" gives a clear selection context, and "(free, no key)" signals it is safe to call without credentials. It does not explicitly name an alternative (e.g. pubmed_search for journal articles) or state when not to use it, so it stops short of full routing guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.